Background The aim of the study was to estimate the sex-specific prevalence and incidence of atrial fibrillation or flutter ...
Please provide your email address to receive an email when new articles are posted on . The AMALFI trial evaluated a completely remote approach to atrial fibrillation screening. Remote screening with ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, announced study results showing no significant differences in detecting ...
Madrid, Spain – 29 August 2025: A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in ...
UK: Portable handheld cardiac ultrasound devices have rapidly become essential tools in emergency rooms, outpatient clinics, ...
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that CEO Robert Eno and CFO Timothy Cruickshank will ...
During a workout it is easy to mistake warning signs for harmless strain. A stitch, a pulled muscle, or reflux can mimic ...
This case highlights the diagnostic value of Holter ECG monitoring in uncovering spontaneous arrhythmia mechanisms. Several ...
BACKGROUND: Early detection of atrial fibrillation (AF) is essential for preventing ischemic stroke and other cardiovascular complications. However, the incidence and prognosis of AF in the general ...
SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from the Oxford University-led Active Monitoring for AtriaL FIbrillation (AMALFI) randomized ...
Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results